Prof Dr. Magdalini Tsolaki | Novel Protocols Awards | Best Researcher Award

Prof Dr. Magdalini Tsolaki | Novel Protocols Awards | Best Researcher Award

Prof Dr. Magdalini Tsolaki, Aristotle University of Thessaloniki, Greece

Dr. Magda Tsolaki, born in Thessaloniki, Greece, pursued Medicine and Theology at Aristotle University of Thessaloniki. She began her collaboration with AUTh in 1982, specializing in Neuropsychiatry and earning her PhD in 1983. As a Professor of Neurology since 2010, she served as Head of the 1st University Department of Neurology (2017-2020) and is now an emeritus professor. Founder of the Greek Alzheimer Association (1995) and the Greek Federation of Alzheimer’s Disease (2007), she chairs both organizations. Dr. Tsolaki established three Public Dementia Units and authored over 285 Greek and 119 English papers, contributing significantly to neurology with an impressive impact factor and citations. Her contributions include 70 books, extensive lecturing, and leadership in dementia research and advocacy. She has received numerous awards and is involved in national and international dementia initiatives.

Professional Profile:

Orcid
Scopus

πŸŽ“ Education:

Studied Medicine (1972-1978) and Theology (1981-1985) at Aristotle University of Thessaloniki, Greece. Received PhD in Neuropsychiatry in 1983.

πŸ‘©β€πŸ« Professional Roles:

Professor of Neurology since 2010, Head of the 1st University Department of Neurology (2017-2020), now Emeritus Professor.

πŸ₯ Medical Leadership:

Founder of Greek Alzheimer Association (1995) and Greek Federation of Alzheimer’s Disease (2007). Scientific director of three Public Dementia Units.

πŸ“š Research & Publications:

Author of 285 Greek and 119 English papers, with 52,358 citations and h-index of 105. Published 70 books and numerous abstracts.

πŸ† Awards & Recognition:

Received 79 awards, participated in 81 funded research programs and 48 clinical trials. Invited speaker at over 493 conferences.

πŸ”¬ Research Interests:

Specializes in neurodegenerative diseases, focusing on Alzheimer’s disease. Actively involved in dementia research and advocacy.

Publication Top Notes:

  • Title: Subjective Cognitive Impairment Can Be Detected from the Decline of Complex Cognition: Findings from the Examination of Remedes 4 Alzheimer’s (R4Alz) Structural Validity
    • Year: 2024
  • Title: Attitudes of Family Members and Caregivers Regarding Alzheimer’s Disease Pre-Symptomatic Screening
    • Year: 2024
  • Title: Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer’s Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study
    • Year: 2024
  • Title: Discriminant Potential of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in Greek Older Adults with Subjective Cognitive Decline and Mild Cognitive Impairment
    • Year: 2024
  • Title: Association of MGMT and BIN1 genes with Alzheimer’s disease risk across sex and APOE Ξ΅4 status
    • Year: 2024

 

 

 

Dr. Yi Zhang | Novel Protocols | Best Researcher Award

Dr. Yi Zhang | Novel Protocols | Best Researcher Award

Β Dr. Yi Zhang, Nankai University, China

Dr. Yi Zhang is a PhD candidate in Organic Chemistry at Nankai University, China, under the supervision of Prof. Yu Liu. He obtained his Master’s degree in Chemical Engineering from the same institution and his Bachelor’s degree in Applied Chemistry from Tianjin University of Commerce. His research primarily focuses on supramolecular chemistry, with significant contributions to the field including the development of novel elastomers and hydrogels with reversible luminescence behavior. Zhang has presented his work at numerous academic conferences and has been recognized with university-level scholarships. He is proficient in English and possesses strong computer skills, including proficiency in Microsoft Office and ChemDraw. Zhang has also actively engaged in extracurricular activities, including serving as Secretary for the Party Branch of the Organic Chemistry Organization.

🌐 Professional Profiles :

Orcid

πŸŽ“ Education :

  • PhD in Organic Chemistry, Nankai University (985), Supervisor: Prof. Yu Liu
  • Master of Chemical Engineering, Nankai University (985), Supervisor: Prof. Yu Liu
  • Bachelor of Applied Chemistry, Tianjin University of Commerce

πŸ… Academic Achievements:

  • Published multiple papers in prestigious journals like Adv. Sci. and Adv. Opt. Mater.
  • Expertise in supramolecular chemistry, with a focus on mechanical and photo-responsive materials.

πŸ‘©β€πŸ« Extracurricular Activities:

  • Served as Secretary of the Party Branch of Organic Chemistry Organization.
  • Organized events like the ‘Graduate Farewell’ and international conferences.

πŸ—£οΈ Language & Computer Skills:

  • Fluent in English (CET-6) and proficient in Microsoft Office, Origin, ChemDraw, and MestReNova.

πŸ† Honors & Scholarships:

  • Recipient of university-level scholarships and the Wanxiang Conference Scholarship.

πŸ“ Certificates:

  • Holds a Second-level Certificate for National Computer.

πŸŽ“ Academic Conferences:

  • Participated in various national and international conferences on cyclodextrin and supramolecular chemistry.

πŸ”¬ Research Interests:

Dr. Yi Zhang’s current research interests revolve around developing novel protocols and technologies for anti-counterfeiting measures. With a focus on innovative solutions, Zhang aims to tackle the growing challenges of counterfeit products through cutting-edge scientific advancements. πŸ›‘οΈ

Publications Top NotesΒ  :

1.Β  Mechanical Stretch α‐Cyclodextrin Pseudopolyrotaxane Elastomer with Reversible Phosphorescence Behavior

Advanced Science published in 2024

2.Β  Slide‐Ring Supramolecular Mechanoresponsive Elastomer with Reversible Luminescence Behavior

Advanced Optical Materials published in 2023

3.Β  Photo‐Controlled Reversible Multicolor Room‐Temperature Phosphorescent Solid Supramolecular Pseudopolyrotaxane

Advanced Optical Materials published in 2022

4.Β  Supramolecular Assemblies of Multi-Charged Cyclodextrins

Chinese Journal of Organic Chemistry published in 2020

5.Β  Construction and efficient dye adsorption of supramolecular hydrogels by cyclodextrin pseudorotaxane and clay

Soft Matter published in 2019

 

 

 

 

 

Dr. Yajing Sun | Novel Protocols | Best Researcher Award

Dr. Yajing Sun | Novel Protocols | Best Researcher Award

Dr. Yajing Sun, University of Oklahoma Health Sciences Center, United States

Dr. Yajing Sun is an accomplished pharmaceutical scientist based at the University of Oklahoma Health Sciences Center, where she earned her Doctor of Philosophy in December 2021. Her academic journey began at Stony Brook University, where she achieved a Master of Science in Chemistry in May 2015, following her Bachelor of Science in Marine Pharmaceutical Science at China Pharmaceutical University in June 2013. 🌐 With a diverse educational background, Dr. Sun brings a wealth of knowledge and expertise to the pharmaceutical field, showcasing a commitment to advancing scientific research and innovation. πŸ”¬ As a dedicated researcher, her interests span novel protocols in pharmaceutical science, with a focus on intracellular protein translocation. Leveraging her expertise, she incorporates cutting-edge technologies like machine-learning image processing into her work. πŸ€–πŸ’‘ Dr. Sun’s contributions extend to the critical realm of human cancer tumors, where her multifaceted approach actively contributes to innovative solutions and breakthroughs in cancer research. 🌟 Her commitment to pushing the boundaries of knowledge makes Dr. Yajing Sun a valuable and dynamic contributor to the evolving field of pharmaceutical science. πŸ‘©β€πŸ”¬πŸŽ‰

πŸŽ“Β Education :

Dr. Yajing Sun is a highly accomplished individual in the field of pharmaceutical science, earning her Doctor of Philosophy from the University of Oklahoma Health Science Center in December 2021. Her academic journey began at Stony Brook University, where she attained a Master of Science in Chemistry in May 2015. Prior to her studies in the United States, she completed her Bachelor of Science in Marine Pharmaceutical Science at China Pharmaceutical University in June 2013. 🌐 With a diverse educational background, Dr. Sun brings a wealth of knowledge and expertise to the pharmaceutical field, demonstrating her commitment to advancing scientific research and innovation. Congratulations to Dr. Yajing Sun on her impressive academic achievements! πŸŽ‰

🌐 Professional Profiles :

Google Scholar

Scopus

🧠Research Interests πŸ”¬πŸŒ :

πŸ”¬ Dr. Yajing Sun is a dedicated researcher with a passion for advancing pharmaceutical science. Her primary research interests encompass novel protocols in pharmaceutical science, focusing on cutting-edge areas such as intracellular protein translocation. 🧬 Leveraging her expertise, she also delves into the intersection of technology and healthcare, incorporating machine-learning image processing techniques into her work. πŸ€–πŸ’‘ Dr. Sun’s research extends to the critical realm of human cancer tumors, where she actively contributes to the quest for innovative solutions and breakthroughs in cancer research. 🌟 Her multifaceted approach and commitment to pushing the boundaries of knowledge make Dr. Yajing Sun a valuable contributor to the field of pharmaceutical science. πŸ‘©β€πŸ”¬πŸŽ“

Publications Top NotesΒ  :

1.Β  Far-red light-activatable prodrug of paclitaxel for the combined effects of photodynamic therapy and site-specific paclitaxel chemotherapy

Journal: Journal of Medicinal Chemistry

Published Year: 2016, Cited By: 106

2.Β  Mitomycin C Induces Immunogenic Cell Death Biomarkers In Human Bladder Tumors

Journal: The FASEB Journal

Published Year: 2020

3.Β  Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Journal: Journal of Controlled Release

Published Year: 2024